H
Henry R. Black
Researcher at Rush University Medical Center
Publications - 207
Citations - 92296
Henry R. Black is an academic researcher from Rush University Medical Center. The author has contributed to research in topics: Blood pressure & Prehypertension. The author has an hindex of 74, co-authored 206 publications receiving 88350 citations. Previous affiliations of Henry R. Black include University of Erlangen-Nuremberg.
Papers
More filters
Journal ArticleDOI
Blood pressure control
TL;DR: To ensure that hypertensive patients receive adequate therapy, physicians should treat patients aggressively and appropriately, avoiding antihypertensive drugs that adversely affect comorbid conditions and selecting those that also exert favorable therapeutic effects on these conditions.
Journal ArticleDOI
The Addition of Doxazosin to the Therapeutic Regimen of Hypertensive Patients Inadequately Controlled with Other Antihypertensive Medications: A Randomized, Placebo-Controlled Study
TL;DR: It is demonstrated that doxazosin add-on therapy is an effective, well-tolerated treatment strategy for patients with inadequately controlled hypertension.
Journal ArticleDOI
Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?
Domenic A. Sica,Henry R. Black +1 more
TL;DR: If angiotensin receptor blocker therapy is being considered in a patient with prior ACE inhibitor‐related angioedema there should be some justification for the use, which might include the presence of heart failure or proteinuric nephropathic states among other considerations.
Journal ArticleDOI
Incidence and Predictors of Angioedema in Elderly Hypertensive Patients at High Risk for Cardiovascular Disease: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Linda B. Piller,Charles E. Ford,Barry R. Davis,Chuke Nwachuku,Henry R. Black,Suzanne Oparil,Tamrat M. Retta,Jeffrey L. Probstfield +7 more
TL;DR: The occurrence of angioedema in the angiotensin‐converting enzyme inhibitor arm corresponds with previously reported angioEDema–angiotens in‐conversion enzyme inhibitor associations.